Page last updated: 2024-11-04

sulforaphane and Ciliary Motility Disorders

sulforaphane has been researched along with Ciliary Motility Disorders in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Ciliary Motility Disorders: Conditions caused by abnormal CILIA movement in the body, usually causing KARTAGENER SYNDROME, chronic respiratory disorders, chronic SINUSITIS, and chronic OTITIS. Abnormal ciliary beating is likely due to defects in any of the 200 plus ciliary proteins, such as missing motor enzyme DYNEIN arms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, YP1
Tsai, IC1
Morleo, M1
Oh, EC1
Leitch, CC1
Massa, F1
Lee, BH1
Parker, DS1
Finley, D1
Zaghloul, NA1
Franco, B1
Katsanis, N1

Other Studies

1 other study available for sulforaphane and Ciliary Motility Disorders

ArticleYear
Ciliopathy proteins regulate paracrine signaling by modulating proteasomal degradation of mediators.
    The Journal of clinical investigation, 2014, Volume: 124, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Cell Line; Ciliary Motility Disorders; Humans; I-kappa B Proteins;

2014